Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinsońs disease

Metabolic Brain Disease

Volumn 24, Issue 2, 2009, Pages 257-269

  Dos Santos, Eliseu Felippe ^a   Busanello, Estela Natacha Brandt ^c   Miglioranza, Anelise ^c   Zanatta, Ângela ^b   Barchak, Alethea Gatto ^c   Vargas, Carmen Regla ^b,c   Saute, Jonas ^c   Rosa, Charles ^d   Carrion, Maria Júlia ^d   Camargo, Daiane ^d   Dalbem, André ^d   Da Costa, Jaderson Costa ^d   De Sousa Miguel, Sandro René Pinto ^c   De Mello Rieder, Carlos Roberto ^c   Wajner, Moacir ^b  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alcohol consumption; Folic acid; Hyperhomocysteinemia; L DOPA; Parkinso s disease; Smoking; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LEVODOPA;

ADULT; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENDER; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MULTIPLE REGRESSION; PARKINSON DISEASE; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LEVODOPA; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; VITAMIN B 12;

PARKINSONIA;

EID: 67349105384     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-009-9139-4     Document Type: Article

References (66)

1. D Aarsland K Andersen JP Larsen A Lolk H Nielsen P Kragh-Sorensen 2001 Risk of dementia in Parkinson's disease: a community-based, prospective study Neurology 56 730 736 (Pubitemid 32240091)
2. AJ Barack HC Beckenhauer KK Kharbanda DJ Tuma 2001 Chronic ethanol consumption increases homocysteine accumulation in hepatocytes Alcohol 2 77 81 (Pubitemid 34016032)
3. LA Bazzano J He P Munter S Vupputuri PK Whelton 2003 Relationship between cigarette smoking and novel risk factors for cardiovascular disease in United Stated Ann Intern Med 138 891 897 (Pubitemid 38124631)
4. JW Beulens A Sierkasma G Schoafsma FJ Kok EA Struys C Jakobs HF Hendriks 2005 Kinetics of Hcy metabolism after moderate alcohol consumption Alcohol Clin Exp Res 29 739 745 (Pubitemid 40686542)
5. F Bladini R Fancellu E Martignonim A Magiagalli C Pacchetti A Samuele G Nappi 2001 Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease Clin Chem 47 1102 1104 (Pubitemid 32493598)
6. C Blasco J Caballeria R Deulofen A Lligona A Pares JM Lluis A Gual J Rodes 2005 Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics Alcohol Clin. Exp. 29 739 745
7. S Bleich D Degner B Bandelow N Von Ahsen E Ruther J Kornhuber 2000 Plasma homocysteine is a predictor of alcohol withdrawal seizures NeuroReport 11 2749 2752
8. BC Blount MM Mack CM Wehr JT Macgregor RA Hiatt G Wang SN Wickramasinghe RB Everson BN Ames 1997 Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implication for cancer and neuronal damage Proc Natl Acad Sci USA 94 3290 3295 (Pubitemid 27157304)
9. T Bottiglieri 1996 Folate, vitamin B12 and neuropsychiatric disorders Nutr Rev 54 382 390 (Pubitemid 27220102)
10. R Castro I Rivera HJ Blom C Jakobs I Tavares de Almeida 2006 Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview J Inherit Metab Dis 29 3 20
11. CL Cher RF Huanh YH Chen JT Cheng TZ Liu 2001 Folate deficiency-induced oxidative stress and apoptosis are cognitive mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhenced activation of NF-kappa B in human Hep G2 cells Biomed Pharmacother 55 434 442 (Pubitemid 32913567)
12. R Clarke AD Smith KA Jobst H Refsum L Sutton PM Ueland 1998 Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch Neurol 55 1449 1455 (Pubitemid 28525506)
13. A de Bree WM Verscuren D Kromhout LA Kluijtmans HJ Blom 2002 Homocysteine determinants and the evidence to what extent homocysteine determinants the risk of coronary heart disease Pharmacol Rev 54 599 618 (Pubitemid 35351198)
14. MC de Rijk MM Breteler JH den Breeijen LJ Launer DE Grobbee FG van der Meché A Hofman 1997 Dietary antioxidants and Parkinson disease. The Rotterdam Study Arch Neurol 54 762 765 (Pubitemid 27255600)
15. R Diaz-Arrastia 2000 Homocysteine and neurologic disease Arch Neurol 57 1422 1427
16. W Duan MP Mattson 1999 Dietary restriction and 2-deoxy-glucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease J Neurosci Res 57 195 206 (Pubitemid 29300322)
17. W Duan B Ladenhein RG Culter II Kruman JL Cadet MP Mattson 2002 Dietary folate deficiency and elevated homocysteine levels endanger dopaminergicneurons in models of Parkinson's disease J Neurochem. 80 101 110 (Pubitemid 34614582)
18. JS Fowler ND Volkow GJ Wang N Pappas J Logan R Macgregor D Alexoff C Shea D Schlyer AP Wolf D Warner I Zezulkova R Cilento 1996 Inhibition of Monoamine-Oxidase-B in the Brains of Smokers Nature 379 733 736
19. A Grieve SP Butcher R Griffiths 1992 Symaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: kinetic characterisation and analysis of carrier specificity J Neurosci Res 32 60 68
20. DB Hancock ER Martin JM Stajich R Jewett MA Stacy BL Scott JM Vance WK Scott 2007 Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease Arch Neurol 64 576 580 (Pubitemid 46588348)
21. GJ Hankey JW Eikelboom 1999 Homocysteine and vascular disease Lancet 354 407 413 (Pubitemid 29355767)
22. S Hassin-Bauer O Coben E Vakil B Sela Z Nitan R Schwartz J Chapman D Tanne 2006 Plasma homocysteine levels and Parkinson's disease: disease progression, carotid intima-media thickness and neuropsychiatric complications Clin Neuropharmacol 29 305 311
23. V Herbert R Zalusky 1962 Interrrelation of vitamin B12 and folic metabolism: folic acid clearance studies J Clin Invest 41 1263 1276
24. B Hultberg M Berdlung A Aandersson A Frank 1993 Elevated plasma homocysteine in alcoholics Alcohol Clin Exp Res 17 687 689 (Pubitemid 23178459)
25. C Isobe T Murata C Sato Y Terayama 2005 Increase of total homocysteine concentration in cereprospinal fluid in patients with Alzheimer's disease and Parkinson's disease Life Sci 15 1836 1843 (Pubitemid 41058987)
26. PF Jacques AG Bostom PW Wilsin S Rich IH Rosenberg J Selhub 2001 Determinants of plasma total homocysteine in the Framingham Offspring cohort Am J Clin Nutr 73 613 621 (Pubitemid 32176514)
27. B Jansson J Jankovic 1985 Low Cancer Rates among Patients with Parkinson's Disease Ann Neurol 17 505 509 (Pubitemid 15019991)
28. P Jenner 1998 Oxidative Mechanisms in Nigral Cell Death in Parkinson's Disease Mov Disord 13 24 34 (Pubitemid 28221476)
29. P Jenner CW Olanow 1996 Oxidative Stress and the Pathogenesis of Parkinson's Disease Neurology 47 161 170
30. DM Kado AS Karlamangla MH Huang A Troen JW Rowe J Selhub TE Seeman 2005 Homocysteine versus the vitamins folate, B6 and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging Am J Med 118 161 167 (Pubitemid 40202865)
31. DG Kirch AM Alho RJ Wyatt 1988 Hypothesis: a Nicotine-Dopamine Interaction Linking Smoking with Parkinson's Disease and Tardive Dyskinesia Cell Mol Neurobiol 8 285 291 (Pubitemid 18240526)
32. II Kruman TS Kumaravel A Lohani WA Pedersen RG Cutler Y Kruman N Haughney J Lee M Evans MP Mattson 2002 Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in animal models of Alzheimer's disease J Neurosci. 22 1752 1762 (Pubitemid 35386293)
33. W Kuhn R Roebroek H Blom D Van Oppenraaj H Przuntek A Kretschmer T Buttner D Woitalla T Muller 1998 Elevated plasma levels of homocysteine in Parkinson's disease Eur Neurol 40 225 227 (Pubitemid 28526247)
34. W Kuhn T Hummel D Woitalla T Muller 2001 Plasma homocysteine and MTHFR C677T genotype in levodopa-trated patients with PD Neurology 56 281 282
35. P Lamberti S Zoccolella E Armenise SV Lamberti A Fraddosio M De Mari G Iliceto P Livrea 2005 Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration Eur J Neurol 12 365 368 (Pubitemid 40524176)
36. JW Langston 1998 Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate Ann Neurol 44 S45 S52 (Pubitemid 28423827)
37. LM Lau PJ Koudstaal JBJ Van Meurs AG Uitterlinder A Hofman MMB Breteler 2005 Methylenetetrahydrofolate reductase C677T genotype and PD Ann Neurol 57 927 930 (Pubitemid 40798634)
38. JW Lazarewicz A Ziembowicz E Matyja A Stafiej E Zieminska 2003 Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: in vivo microdialysis study Neurochem Res 2 259 269 (Pubitemid 36207350)
39. SA Lipton WK Kim YB Choi S Kumar DM D'Emilia PV Rayudu DR Arnelle JS Stamler 1997 Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor Proc Natl Acad Sci U.S.A. 94 5923 5928 (Pubitemid 27241873)
40. MJ Magera JM Lacey B Casetta P Rinaldo 1999 Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry Clin Chem 45 1517 1522 (Pubitemid 29419005)
41. CD Marsden 1994 Parkinson's disease J Neurol Neurosurg Psychiatry 57 672 681 (Pubitemid 24182950)
42. SP Mooijaart J Gussekloo M Frolich J Jolles DJ Stott RG Westendorp AJ de Craen 2005 Homocysteine, vitamin B12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study Am J Clin Nutr 82 866 871 (Pubitemid 43779702)
43. T Muller B Werne B Fowler W Kuhn 1999 Nigral endothelial disfunction, homocysteine, and Parkinson's disease Lancet 354 126 127 (Pubitemid 29313150)
44. T Muller D Woitalla W Kuhn 2003 Benefit of folic acid supplementation in parkinsonian patients treated qith levodopa J Neurol Neurosurg Psychiatry 74 549 (Pubitemid 36379395)
45. PE O' Suilleabhain V Sung C Hernandez L Laccritz RB Dewey Jr T Bottiglieri R Diaz-Arrastia 2004 Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations Arch Neurol 61 865 868 (Pubitemid 38747325)
46. R Obeid W Herrman 2006 Mechanisms of homocysteine neurotoxixity in neurodegenerative diseases with special reference to dementia FEBS Lett 580 2994 3005 (Pubitemid 43744523)
47. M Quik 2004 Smoking, nicotine and Parkinson's disease Trends Neurosci 27 561 568 (Pubitemid 39149826)
48. D Religa K Czyewski M Stycznska B Peplonska J Lokk M Chodakowska- Zebrowska K Stepein B Winblad M Barcikowska 2006 Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease Neurosci Lett 404 56 60 (Pubitemid 44063604)
49. JD Rogers A Sanchez-Saffon AB Frol R Diaz-Arrastia 2003 Elevated plasma homocysteine levels in pacients treated with levodopoa: association with vascular disease Arch Neurol 60 59 64 (Pubitemid 36078109)
50. PS Sachdev 2005 Homocysteine and brain atrophy Prog Neuropsychopharmacol Biol Psychiatry 29 1152 1161 (Pubitemid 41383514)
51. PS Sachdev M Valenzuela XL Wang JC Looi H Brodaty 2002 Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals Neurology 58 1539 1541 (Pubitemid 34552965)
52. SM Saw JM Yuan CN Ong K Arakawa HP Lee GA Coetzee MC Yu 2001 Genetic, dietary and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and woman in Singapore Am J Clin Nutr 73 232 239 (Pubitemid 32111746)
53. JM Scott JJ Dinn P Wilson DGP Weir 1981 Pathogenesis of subacute combined degeneration: a result of methylgroup deficiency Lancet 2 334 337 (Pubitemid 11040582)
54. J Selhub 2006 The many facets if hiperhomocysteinemia: studies from the Framingham Cohorts J Nutr 136 1726 1730 (Pubitemid 43765388)
55. HR Silva NL Khan NW Wood 2000 The genetics of Parkinson's disease Curr Opin Genet Dev 10 292 298 (Pubitemid 30307248)
56. A Siniscalchi L Gallelli NB Mercuri GF Ibbadu G Sarro 2006 Role of lifestyle factors on plasma homocysteine levels in Pakinson's disease patients treated with levodopa Nutr Neuosci 9 11 6 (Pubitemid 44057026)
57. EL Streck AI Zugno B Tagliari C Wannmacher M Wajner AT Wyse 2002 Inhibition of Na+, K+- ATPase activity by the metabolites accumulating in homocystinuria Metab Brain Dis 17 83 91 (Pubitemid 34655047)
58. EL Streck D Delwing B Tagliari C Matte CM Wannmacher M Wajner AT Wyse 2003 Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria Neurochem Int 43 597 602 (Pubitemid 36724959)
59. NA Tatton 2000 Increased caspase 3 and bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease Exp Neurol 166 29 43
60. CA Taylor MH Saind-Hilaire LA Cupples CA Thomas AE Burchard RG Felman RH Myers 1999 Environmental, medical, and family history risk factors for Parkinson's disease: a New England base control study Am J Med Genet 88 742 749
61. Z Todorovic E Dzoljic I Novakovic D Mirkovic R Stojanovic Z Nesic M Krajinovic M Prostran V Kostci 2006 Homocysteine serum levels and MTHFH C677T genotyoe in patients with Parkinson's disease, with and without levopoda therapy J Neurol Sci 248 56 61 (Pubitemid 44647314)
62. GR Upchurch GN Welch AJ Fabian JE Freedman JE Johnson JF Keany J Loscalzo 1997 Homocysteine decreases bioavailable nitrie oxide by a mechanism involving glutathione peroxidase J Biol Chem 272 17012 17017 (Pubitemid 27289806)
63. M Van der Gaag JB Ubbink P Sillanaukee S Nikkari HFJ Endriks 2000 Effect of consumption of red wine, spirits and beer on serum homocysteine Lancet 355 1522 (Pubitemid 30237364)
64. RT Wall JM Harlam LA Harker GE Striker 1980 Homocysteine induced endothelial cell injury in vitro: a model fot the study of vascular injury Thromb Res 18 113 121 (Pubitemid 10109903)
65. K Yasui H Kowa K Nakaso T Takeshima K Nakashima 2000 Plasma homocysteine and MTHFR C6677T genotype in levopoda treated patients with PD Neurology 55 437 440 (Pubitemid 30650089)
66. S Zoccolella P Lamberti G Iliceto C Diroma E Armenise G Defazio SV Lamberti A Fraddosio M de Mari P Livrea 2005 Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions Clin Chem Lab Med 43 1107 1110 (Pubitemid 41581969)